Finance

Lists
INNO:CNSX
Innocan Pharma Corp
1,90 CA$
0,00%
(0,00) 1D
15 հոկ, 14:52:58 GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for INNO...
Mkt. cap
8,99 մլն
Avg. vol.
1,42 հզր
Volume
0,00
52-wk high
19,15 CA$
52-wk low
1,60 CA$
EPS
-0,30 CA$
No. of employees
8
Mkt. cap
8,99 մլն
Avg. vol.
1,42 հզր
Volume
0,00
52-wk high
19,15 CA$
52-wk low
1,60 CA$
EPS
-0,30 CA$
No. of employees
8
News stories
From web sources and news partners
About Innocan Pharma Corp
CEO-
Employees8
Founded2017
Headquarters-
Sector-
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
6,82 մլն
4,99 մլն
6,46 մլն
5,25 մլն
Cost of goods sold
631,00 հզր
558,00 հզր
575,00 հզր
481,00 հզր
Cost of revenue
631,00 հզր
558,00 հզր
575,00 հզր
481,00 հզր
Research and development expenses
415,00 հզր
161,00 հզր
184,00 հզր
-9,00 հզր
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6,99 մլն
5,19 մլն
6,49 մլն
5,29 մլն
Operating expense
7,41 մլն
5,35 մլն
6,68 մլն
5,28 մլն
Total operating expenses
8,04 մլն
5,91 մլն
7,25 մլն
5,76 մլն
Operating income
-1,22 մլն
-922,00 հզր
-786,00 հզր
-508,00 հզր
Other non operating income
-200,00 հզր
1,93 մլն
7,00 հզր
330,00 հզր
EBT including unusual items
-1,43 մլն
1,59 մլն
-822,00 հզր
-214,00 հզր
EBT excluding unusual items
-1,30 մլն
1,00 մլն
-786,00 հզր
-184,00 հզր
Income tax expense
220,00 հզր
-262,00 հզր
64,00 հզր
-64,00 հզր
Effective tax rate
-15,36%
-16,45%
-7,79%
29,91%
Other operating expenses
-
-
-
-
Net income
-1,95 մլն
2,00 մլն
-972,00 հզր
-34,00 հզր
Net profit margin
-28,54%
40,00%
-15,03%
-0,65%
Earnings per share
-
-
-
-
Interest and investment income
7,00 հզր
-
-
10,00 հզր
Interest expense
-
-3,00 հզր
-7,00 հզր
-16,00 հզր
Net interest expenses
7,00 հզր
-3,00 հզր
-7,00 հզր
-6,00 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-1,21 մլն
-910,00 հզր
-778,00 հզր
-503,00 հզր
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google Apps